Difference between revisions of "Team:San Andres/Collaborations"
San Andres (Talk | contribs) |
San Andres (Talk | contribs) |
||
| Line 1: | Line 1: | ||
| + | <!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd"> | ||
<html> | <html> | ||
<head> | <head> | ||
| Line 254: | Line 255: | ||
onmouseover="this.bgColor='#ffba00'" | onmouseover="this.bgColor='#ffba00'" | ||
onmouseout="this.bgColor='#fcff00'" align="center" | onmouseout="this.bgColor='#fcff00'" align="center" | ||
| − | bgcolor="# | + | bgcolor="#fcff00" height="45"> |
<a href="https://2015.igem.org/Team:San_Andres/Results" | <a href="https://2015.igem.org/Team:San_Andres/Results" | ||
style="color: rgb(0, 0, 0);"> Results </a> | style="color: rgb(0, 0, 0);"> Results </a> | ||
| Line 261: | Line 262: | ||
onmouseover="this.bgColor='#ffba00'" | onmouseover="this.bgColor='#ffba00'" | ||
onmouseout="this.bgColor='#fcff00'" align="center" | onmouseout="this.bgColor='#fcff00'" align="center" | ||
| − | bgcolor="# | + | bgcolor="#fcff00" height="45"> |
<a href="https://2015.igem.org/Team:San_Andres/Collaborations" | <a href="https://2015.igem.org/Team:San_Andres/Collaborations" | ||
style="color: rgb(0, 0, 0);"> Future Projections </a> | style="color: rgb(0, 0, 0);"> Future Projections </a> | ||
| Line 304: | Line 305: | ||
</div> | </div> | ||
</div> | </div> | ||
| − | + | <big> | |
| − | <big | + | |
<br> | <br> | ||
</big> | </big> | ||
Revision as of 00:08, 6 July 2015
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
| Home | Team | Project | Statistics | Enzymes | Parts | Metodology | Results | Future Projections |
 |
Future Projections
If our results are the expected our future projections are the following:- Be one of the first Latin American teams at the school level in the IGEM competition.
- Disclosure to the scientific community.
- Realize workshops in academic institutions of this enteropathy with the aim of being more known in society.
- Generate the product and market it for therapeutic purposes.
If all goes
well, we going to patenting our pill, which give us licenses which we
can sell to pharmacies and laboratories to produce the medication and
sell it to celiac patients. This would mean a social benefit and an
benefict for us.
